Adalimumab (Humira)

Adalimumab (Humira) image

Pathology home » Pathology tests A to Z » Adalimumab (Humira)

Pathology category

Biochemistry - referred tests

Code

ADAL

Referral code

Request form

Test information

Monitoring of patients on adalimumab (humira) therapy

Guidelines

Pre-analytical

Ideally trough samples should be collected (i.e. just before next dose). Samples should be separated within 4 hours of collection.

Reference range

Tube type

Serum  (EDTA plasma also suitable) — SST

Tube type info

Serum (EDTA plasma also suitable) — SST

Special requirements

Minimum volume

Assay frequency

TAT Inpatient (urgent)

2 weeks

TAT Inpatient

2 weeks

TAT GP/Outpatient

2 weeks

Referral lab

Birmingham City